Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Multiple physiological effects of GLP-1[1] Medications for diabetes comprise either GLP-1 receptor agonists, with short (one or two daily injections: Exenatide, Liraglutide, Lixisenatide) or long duration (one injection once weekly: extended-released Exenatide, Albiglutide, Dulaglutide, Taspoglutide)
Each component of CS10 has its own clinical program: semaglutide in the STEP (obesity) and SUSTAIN (type 2 diabetes) studies, and cagrilintide in a dose-finding phase 2 study in obesity
This sustained weight loss translates to better overall health and quality of life
Seek immediate emergency care if you suspect a reaction
US$ 27.80
US$ 26.10
US$ 25.82
